Abstract
Children with Down syndrome (DS) present with a spectrum of hematolymphoid malignancies ranging from transient myeloproliferative disorder (TMD) which regress spontaneously to frank acute leukemia of both myeloid and lymphoid lineage. Here we present a series of three cases with different manifestation in DS. Three cases of DS presented with TMD, acute myeloid leukemia (AML–M2) and acute megakaryoblastic leukemia (AMKL), respectively. This case series displays the spectrum of hematological manifestations in children with DS. Although TMD and AMKL are strongly associated with DS, other AML subtypes can also be seen in such patients.
References
Rabin KR, Whitlock JA (2009) Malignancy in children with trisomy 21. Oncologist 14:164–173
Massey GV, Zipursky A, Chang MN, Doyle JJ, Nasim S, Taub JW et al (2006) A prospective study of the natural history of transient leukemia (TL) in neonates with Down syndrome (DS): Children Oncology Group (COG) study POG-9481. Blood 107:4606–4613
Baumann I, Niemeyer CM, Brunning RD, Arber DA, Porwit A (2008) Myeloid proliferations related to Down syndrome. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al (eds) WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. IARC, Lyon, pp 142–144
Roizen NJ, Patterson D (2003) Down’s syndrome. Lancet 361:1281–1289
Zipursky A, Brown EJ, Christensen H, Doyle J (1999) Transient myeloproliferative disorder (transient leukemia) and hematologic manifestations of Down syndrome. Clin Lab Med 19:157–167
Zipursky A, Brown E, Christensen H, Sutherland R, Doyle J (1997) Leukemia and/or myeloproliferative syndrome in neonates with Down syndrome. Semin Perinatol 21:97–101
Bhatt S, Schreck R, Graham JM et al (1995) Transient leukemia with trisomy 21. Am J Med Genet 58:310–314
Aier M, Zadeng T, Basu D, Biswal N, Nalini P (2002) Congenital leukemia in Down syndrome–a case report. Indian J Pathol Microbiol 45:355–357
Homans AC, Verissimo AM, Vlacha V (1993) Transient abnormal myelopoiesis of infancy associated with trisomy 21. Am J Pediatr Hematol Oncol 15:392–397
Karandikar NJ, Aquino DB, McKenna RW, Kroft SH (2001) Transient myeloproliferative disorder and acute myeloid leukemia in Down syndrome. Am J Clin Pathol 116:204–210
Ahmed M, Sternberg A, Hall G, Thomas A, Smith O, O’Marcaigh A et al (2004) Natural history of GATA 1 mutations in Down syndrome. Blood 103:2480–2489
Ge Y, Stout ML, Tatman DA, Jensen TL, Buck S, Thomas RL (2005) GATA1, cytidine deaminase, and the high cure rate of Down syndrome children with acute megakaryocytic leukemia. J Natl Cancer Inst 97:226–231
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Manivannan, P., Prasaad, P.R., Kar, R. et al. Down Syndrome with Different Hematological Manifestations: A Short Series of 3 Cases with Review of Literature. Indian J Hematol Blood Transfus 29, 31–34 (2013). https://doi.org/10.1007/s12288-011-0134-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12288-011-0134-7